|
Volumn 38, Issue 12, 1997, Pages 1265-1269
|
Evaluation of case reports of aplastic anemia among patients treated with Felbamate
|
Author keywords
Aplastic anemia; Case reports; Felbamate; Risk evaluation
|
Indexed keywords
ACETYLSALICYLIC ACID;
ALPHAPRODINE;
AMOXICILLIN;
AMPICILLIN;
CARBAMAZEPINE;
COTRIMOXAZOLE;
DIGOXIN;
FELBAMATE;
FLUPHENAZINE;
FUROSEMIDE;
GABAPENTIN;
MESUXIMIDE;
NAPROXEN;
OMEPRAZOLE;
PHENOBARBITAL;
PHENYTOIN;
PREDNISONE;
SALAZOSULFAPYRIDINE;
SUMATRIPTAN;
VALPROATE SEMISODIUM;
VALPROIC ACID;
VERAPAMIL;
ADULT;
ANTICONVULSANT THERAPY;
APLASTIC ANEMIA;
ARTICLE;
BLOOD TOXICITY;
CLINICAL ARTICLE;
CLINICAL FEATURE;
CONTROLLED STUDY;
DRUG SAFETY;
FEMALE;
HUMAN;
MALE;
PRIORITY JOURNAL;
RISK ASSESSMENT;
SEIZURE;
ADULT;
ADVERSE DRUG REACTION REPORTING SYSTEMS;
ANEMIA, APLASTIC;
ANTICONVULSANTS;
CAUSALITY;
CONFOUNDING FACTORS (EPIDEMIOLOGY);
EPILEPSY;
FEMALE;
HUMANS;
INCIDENCE;
MALE;
MEDICAL RECORDS;
PROPYLENE GLYCOLS;
RISK ASSESSMENT;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
EID: 0031440072
PISSN: 00139580
EISSN: None
Source Type: Journal
DOI: 10.1111/j.1528-1157.1997.tb00062.x Document Type: Article |
Times cited : (135)
|
References (9)
|